Header Logo

Connection

PAOLO ANDERLINI to Blood Donors

Back to Details
This is a "connection" page, showing publications PAOLO ANDERLINI has written about Blood Donors.
PAOLO ANDERLINI
Connection Strength
1.482
Blood Donors
  1. Peripheral blood stem cell donation: an analysis from the International Bone Marrow Transplant Registry (IBMTR) and European Group for Blood and Marrow Transplant (EBMT) databases. Bone Marrow Transplant. 2001 Apr; 27(7):689-92.
    View in: PubMed
    Score: 0.179
  2. Blood stem cell procurement: donor safety issues. Bone Marrow Transplant. 1998 Jun; 21 Suppl 3:S35-9.
    View in: PubMed
    Score: 0.147
  3. Allogeneic blood stem cell transplantation: considerations for donors. Blood. 1997 Aug 01; 90(3):903-8.
    View in: PubMed
    Score: 0.139
  4. Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion. 1997 May; 37(5):507-12.
    View in: PubMed
    Score: 0.137
  5. The use of mobilized peripheral blood stem cells from normal donors for allografting. Stem Cells. 1997; 15(1):9-17.
    View in: PubMed
    Score: 0.134
  6. Peripheral blood stem cell apheresis in normal donors: the neglected side. Blood. 1996 Nov 01; 88(9):3663-4.
    View in: PubMed
    Score: 0.132
  7. Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program. Blood. 2013 Jan 03; 121(1):197-206.
    View in: PubMed
    Score: 0.100
  8. Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center. Leuk Lymphoma. 2012 Jun; 53(6):1239-41.
    View in: PubMed
    Score: 0.094
  9. Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose. Blood. 2009 Sep 24; 114(13):2606-16.
    View in: PubMed
    Score: 0.080
  10. Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program. Blood. 2009 Apr 09; 113(15):3604-11.
    View in: PubMed
    Score: 0.077
  11. Hematopoietic growth factors--use in normal blood and stem cell donors: clinical and ethical issues. Transfusion. 2008 Sep; 48(9):2008-25.
    View in: PubMed
    Score: 0.074
  12. A comparative study of once-daily versus twice-daily filgrastim administration for the mobilization and collection of CD34+ peripheral blood progenitor cells in normal donors. Br J Haematol. 2000 Jun; 109(4):770-2.
    View in: PubMed
    Score: 0.042
  13. Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study. Biol Blood Marrow Transplant. 2019 04; 25(4):699-711.
    View in: PubMed
    Score: 0.038
  14. Mobilization kinetics of CD34+/Thy-1dim progenitor cells during recombinant human granulocyte-colony-stimulating factor administration in normal donors. Transfusion. 1997 Apr; 37(4):406-10.
    View in: PubMed
    Score: 0.034
  15. Peripheral blood stem cell apheresis in normal donors: feasibility and yield of second collections. Br J Haematol. 1997 Feb; 96(2):415-7.
    View in: PubMed
    Score: 0.034
  16. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood. 1995 Oct 01; 86(7):2842-8.
    View in: PubMed
    Score: 0.031
  17. Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis. J Clin Apher. 2001; 16(2):82-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.